Results 301 to 310 of about 609,075 (334)

Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL):

Clinical Laboratory, 2016
Oxidized low-density lipoprotein (ox-LDL) plays a principal role in diabetes complications, though ox-LDL concentrations and its functions are dependents of other oxidative and anti-oxidative particles. The oxLDL to low-density lipoprotein ratio (ox-LDL/LDL) and ox-LDL to high-density lipoprotein ratio (ox-LDL/HDL) as new lipid biomarkers may serve as ...
Mahtab, Motamed, Arash A, Nargesi, Behnam, Heidari, Hossein, Mirmiranpour, Alireza, Esteghamati, Manouchehr, Nakhjavani   +5 more
openaire   +2 more sources

Carbamylated LDL

2010
Nonenzymatic modification of protein by cyanate, that is, carbamylation, has received new attention due to its apparent relevance in atherosclerosis. For example, carbamylation of low-density lipoprotein (LDL) is an important mechanism that potentially impacts high-risk atherosclerotic individuals with increased urea (renal insufficiency) or ...
Alexei G, Basnakian, Sudhir V, Shah, Ercan, Ok, Ekrem, Altunel, Eugene O, Apostolov   +4 more
openaire   +2 more sources

LDL apheresis

Atherosclerosis, 2003
Low density lipoprotein (LDL) apheresis provides a safe and effective means of treating patients with homozygous familial hypercholesterolaemia (FH). It also has a role in preventing the progression of coronary artery disease in heterozygotes and others with severe dyslipidaemia who are refractory to or intolerant of high doses of lipid-lowering drugs.
openaire   +2 more sources

Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL

Atherosclerosis, 1998
Estimation of LDL-chol and LDL-apo B is useful for the diagnosis of hyperapobetalipoproteinemia (normal LDL-chol with increased LDL-apo B), which is one of the most commonly occurring lipoprotein disorders associated with atherosclerotic cardiovascular diseases.
Y, Hattori, M, Suzuki, M, Tsushima, M, Yoshida, Y, Tokunaga, Y, Wang, D, Zhao, M, Takeuchi, Y, Hara, K I, Ryomoto, M, Ikebuchi, H, Kishioka, T, Mannami, S, Baba, Y, Harano   +14 more
openaire   +2 more sources

LDL Receptor's β-Propeller Displaces LDL

Science, 2002
The low density lipoprotein receptor (LDLR) binds to lipoprotein extracellularly and releases it in the endosome. In his Perspective, Innerarity discusses new structural work (Rudenkoet al.) that shows that an interdomain interaction that occurs at low pH likely displaces ligand from the receptor in the endosome.
openaire   +1 more source

LDL-apheresis therapy

Current Treatment Options in Cardiovascular Medicine, 2006
Low-density lipoprotein (LDL)-apheresis is an effective means for acutely lowering plasma cholesterol (LDL reduction > 60%) and reducing cardiovascular events in patients with uncontrolled hypercholesterolemia who are genetically predisposed or resistant to standard therapy.
openaire   +2 more sources

Antiatherosclerotic effects of statins: LDL versus non-LDL effects

Current Atherosclerosis Reports, 2007
Cardiovascular risk factors, particularly low-density lipoproteins (LDL), give rise to atherosclerosis and its complications by triggering a dysfunctional endothelium, inflammation, and a procoagulant vascular surface. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibition by statins leads to a fall in circulating and plaque LDL ...
openaire   +2 more sources